NTAGI analyzes data of Covid-19 breakthrough infections in India to decide on booster dose

NEW DELHI: To make a decision regarding a booster dose of the Covid-19 vaccine, the National Technical Advisory Group on Immunisation (NTAGI) is analyzing data of Covid-19 breakthrough infections in India, said sources on Tuesday.
As per the sources, "NTAGI is analyzing data of Covid-19 breakthrough infections in India, to look at the vaccine effectiveness and take a decision regarding additional and booster dose."
During its last meeting, the NTAGI had made no final recommendation on additional Covid-19 vaccine doses and vaccines for children.However, both the issues were discussed in the meeting and the booster dose was not on the agenda of today's meeting.